Advertisement
Review Article| Volume 35, ISSUE 3, P557-573, November 2019

Vaccinating Calves in the Face of Maternal Antibodies

Challenges and Opportunities

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Food Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chase C.C.L.
        • Hurley D.J.
        • Reber A.J.
        Neonatal immune development in the calf and its impact on vaccine response.
        Vet Clin North Am Food Anim Pract. 2008; 24: 87-104
        • Cortese V.S.
        Neonatal immunology.
        Vet Clin North Am Food Anim Pract. 2009; 25: 221-227
        • Firth M.A.
        • Shewen P.E.
        • Hodgins D.C.
        Passive and active components of neonatal innate immune defenses.
        Anim Heal Res Rev. 2005; 6: 143-158
        • Barrington G.M.
        • Parish S.M.
        Bovine neonatal immunology.
        Vet Clin North Am Food Anim Pract. 2001; 17: 463-476
        • McGee M.
        • Earley B.
        Review: passive immunity in beef-suckler calves.
        Animal. 2019; 13: 810-825
        • Godden S.
        Colostrum management for dairy calves.
        Vet Clin North Am Food Anim Pract. 2008; https://doi.org/10.1016/j.cvfa.2007.10.005
        • Waldner C.L.
        • Rosengren L.B.
        Factors associated with serum immunoglobulin levels in beef calves from Alberta and Saskatchewan and association between passive transfer and health outcomes.
        Can Vet J. 2009; 50: 275-281
        • Chigerwe M.
        • Hagey J.V.
        • Aly S.S.
        Determination of neonatal serum immunoglobulin G concentrations associated with mortality during the first 4 months of life in dairy heifer calves.
        J Dairy Res. 2015; 82: 400-406
        • Buczinski S.
        • Gicquel E.
        • Fecteau G.
        • et al.
        Systematic review and meta-analysis of diagnostic accuracy of serum refractometry and Brix refractometry for the diagnosis of inadequate transfer of passive immunity in calves.
        J Vet Intern Med. 2018; https://doi.org/10.1111/jvim.14893
        • Raboisson D.
        • Trillat P.
        • Cahuzac C.
        Failure of passive immune transfer in calves: a meta-analysis on the consequences and assessment of the economic impact.
        PLoS One. 2016; 11: 1-19
        • Ellis J.A.
        • Gow S.P.
        • Mahan S.
        • et al.
        Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
        J Am Vet Med Assoc. 2013; 243: 1602-1608
        • Ellis J.
        • Gow S.
        • Bolton M.
        • et al.
        Inhibition of priming for bovine respiratory syncytial virus-specific protective immune responses following parenteral vaccination of passively immune calves.
        Can Vet J. 2014; 55: 1180-1185
        • Windeyer M.C.
        • Leslie K.E.
        • Godden S.M.
        • et al.
        Association of bovine respiratory disease or vaccination with serologic response in dairy heifer calves up to three months of age.
        Am J Vet Res. 2015; 76: 239-245
        • Chamorro M.F.
        • Walz P.H.
        • Passler T.
        • et al.
        Efficacy of multivalent, modified-live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent bovine viral diarrhea virus type 2.
        BMC Vet Res. 2015; 11: 29
        • Al-Alo K.Z.K.
        • Nikbakht Brujeni G.
        • Lotfollahzadeh S.
        • et al.
        Correlation between neonatal calf diarrhea and the level of maternally derived antibodies.
        Iran J Vet Res. 2018; 19 (Available at:): 3-8
        • Earley B.
        • Tiernan K.
        • Duffy C.
        • et al.
        Effect of suckler cow vaccination against glycoprotein E (gE)-negative bovine herpesvirus type 1 (BoHV-1) on passive immunity and physiological response to subsequent bovine respiratory disease vaccination of their progeny.
        Res Vet Sci. 2018; 118: 43-51
        • Chamorro M.F.
        • Woolums A.
        • Walz P.H.
        Vaccination of calves against common respiratory viruses in the face of maternally derived antibodies (IFOMA).
        Anim Health Res Rev. 2016; 17: 79-84
        • Petrini S.
        • Iscaro C.
        • Righi C.
        Antibody responses to bovine alphaherpesvirus 1 (BoHV-1) in passively immunized calves.
        Viruses. 2019; 11: 23
        • Brar J.S.
        • Johnson D.W.
        • Muscoplat C.C.
        • et al.
        Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves.
        Am J Vet Res. 1978; 39: 241-244
        • Lemaire M.
        • Weynants V.
        • Godfroid J.
        • et al.
        Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency.
        J Clin Microbiol. 2000; 38 (Available at:): 1885-1894
        • Kirkpatrick J.
        • Fulton R.
        • Burge L.
        • et al.
        Passively transferred immunity in newborn calves, rate of antibody decay, and effect on subsequent vaccination with modified live virus vaccine.
        Bov Pract. 2001; 35: 47-54
        • Muñoz-Zanzi C.A.
        • Thurmond M.C.
        • Johnson W.O.
        • et al.
        Predicted ages of dairy calves when colostrum-derived bovine viral diarrhea virus antibodies would no longer offer protection against disease or interfere with vaccination.
        J Am Vet Med Assoc. 2002; 221: 678-685
        • Fulton R.W.
        • Briggs R.E.
        • Payton M.E.
        • et al.
        Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
        Vaccine. 2004; 22: 643-649
        • Niewiesk S.
        Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.
        Front Immunol. 2014; 5: 446
        • Waldner C.L.
        • Parker S.
        • Campbell J.R.
        Vaccine usage in western Canadian cow-calf herds.
        Can Vet J. 2019; 60: 414-422
        • Murray C.F.
        • Fick L.J.
        • Pajor E.A.
        • et al.
        Calf management practices and associations with herd-level morbidity and mortality on beef cow-calf operations.
        Animal. 2016; 10: 468-477
        • Waldner C.
        • Jelinski M.D.
        • McIntyre-Zimmer K.
        Survey of western Canadian beef producers regarding calf-hood diseases, management practices, and veterinary service usage.
        Can Vet J. 2013; 54 (Available at:): 559-564
        • United States Department of Agriculture National Animal Health Monitoring Sytem
        Beef 2007-2008 part IV: reference of beef cow-calf management practices in the United States, 2007-08.
        2010
        • United States Department of Agriculture National Animal Health Monitoring System
        Beef cow/calf health & productivity audit 1993, Part III: beef cow/calf health management.
        1994
        • United States Department of Agriculture National Animal Health Monitoring System
        Dairy herd management practices focusing on preweaned heifer calves, April 1991-July 1992.
        1993
        • United States Department of Agriculture National Animals Health Monitoring System
        Dairy 2014 dairy cattle management practices in the United States, 2014.
        2016
        • Van Donkersgoed J.
        • van den Hurk J.V.
        • McCartney D.
        • et al.
        Comparative serological response in calves to eight commercial vaccines against infectious bovine rhinotracheitis, parainfluenza-3, bovine respiratory syncytial, and bovine viral diarrhea viruses.
        Can Vet J. 1991; 32 (Available at:): 727-733
      1. Woolums AR. Vaccinating calves: new information on the effects of maternal immunity. Proc 40th Annu Conf Am Assoc Bov Pract. Vancouver, BC, Canada, 2007;40. p. 10–7.

        • Platt R.
        • Widel P.W.
        • Kesi L.D.
        • et al.
        Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge.
        Vaccine. 2009; 27: 4508-4519
        • Endsley J.J.
        • Roth J.A.
        • Ridpath J.
        • et al.
        Maternal antibody blocks humoral but not T cell responses to BVDV.
        Biologicals. 2003; 31: 123-125
        • Van Anne T.R.
        • Rinehart C.L.
        • Buterbaugh R.E.
        • et al.
        Cell-mediated and humoral immune responses to bovine herpesvirus type 1 and bovine viral diarrhea virus in calves following administration of a killed-virus vaccine and bovine herpesvirus type 1 challenge.
        Am J Vet Res. 2018; 79: 1166-1178
        • Woolums A.R.
        • Berghaus R.D.
        • Berghaus L.J.
        • et al.
        Effect of calf age and administration route of initial multivalent modified-live virus vaccine on humoral and cell-mediated immune responses following subsequent administration of a booster vaccination at weaning in beef calves.
        Am J Vet Res. 2013; 74: 343-354
        • Ridpath J.E.
        • Neill J.D.
        • Endsley J.
        • et al.
        Effect of passive immunity on the development of a protective immune response against bovine viral diarrhea virus in calves.
        Am J Vet Res. 2003; 64: 65-69
        • Woolums A.R.
        • Berghaus R.D.
        • Smith D.R.
        • et al.
        Producer survey of herd-level risk factors for nursing beef calf respiratory disease.
        J Am Vet Med Assoc. 2013; 243 (Available at:): 538-547
        • Ellis J.A.
        • Gow S.P.
        • Goji N.
        Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
        J Am Vet Med Assoc. 2010; 236: 991-999
        • Zimmerman A.D.
        • Boots R.E.
        • Walli J.L.
        • et al.
        Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine.
        J Am Vet Med Assoc. 2006; 228: 1757-1761
        • Zimmerman A.D.
        • Buterbaugh R.E.
        • Schnackel J.A.
        • et al.
        Efficacy of a modified-live virus vaccine administered to calves with maternal antibodies and challenged seven months later with a virulent bovine viral diarrhea type 2 virus.
        Bov Pract. 2009; 43: 35-43
        • Stevens E.T.
        • Brown M.S.
        • Burdett W.W.
        • et al.
        Efficacy of a non-adjuvanted, modified-live virus vaccine in calves with maternal antibodies against a virulent bovine viral diarrhea virus type 2a challenge seven months following vaccination.
        Bov Pract. 2011; 45: 23-31
        • Ellis J.
        • West K.
        • Cortese V.
        • et al.
        Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves.
        J Am Vet Med Assoc. 2001; 219: 351-356
        • Windeyer M.C.
        • Leslie K.E.
        • Godden S.M.
        • et al.
        The effects of viral vaccination of dairy heifer calves on the incidence of respiratory disease, mortality, and growth.
        J Dairy Sci. 2012; 95: 6731-6739
        • Todd J.D.
        Intranasal vaccination of cattle against IBR and PI3: field and laboratory observations in dairy, beef, and neonatal calf populations.
        Dev Biol Stand. 1976; 33: 391-395
        • Xue W.
        • Ellis J.
        • Mattick D.
        • et al.
        Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
        Vaccine. 2010; 28: 3784-3792
        • Ellis J.
        • Gow S.
        • West K.
        • et al.
        Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
        J Am Vet Med Assoc. 2007; 230: 233-243
        • Vangeel I.
        • Antonis A.F.G.
        • Fluess M.
        • et al.
        Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV.
        Vet J. 2007; 174: 627-635
        • Vangeel I.
        • Ioannou F.
        • Riegler L.
        • et al.
        Efficacy of an intranasal modified live bovine respiratory syncytial virus and temperature-sensitive parainfluenza type 3 virus vaccine in 3-week-old calves experimentally challenged with PI3V.
        Vet J. 2009; 179: 101-108
        • Mahan S.M.
        • Sobecki B.
        • Johnson J.
        • et al.
        Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
        J Am Vet Med Assoc. 2016; 248: 1280-1286
        • Ollivett T.L.
        • Leslie K.E.
        • Duffield T.F.
        • et al.
        Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on calf health, ultrasonographic lung consolidation, and growth in Holstein dairy calves.
        J Dairy Sci. 2018; 101: 8159-8168
        • Stokka G.L.
        • Neville B.
        • Seeger J.T.
        • et al.
        Serological effect of two concurrent IBRV, BVDV, BRSV, PI3V, and Mannheimia haemolytica vaccination protocols and time interval between the first and second dose on the subsequent serological response to the BRSV and M. haemolytica fractions in suckling beef calves.
        Bov Pract. 2016; 50: 21-27
        • Cortese V.S.
        • Seeger J.T.
        • Stokka G.S.
        • et al.
        Serologic response to Mannheimia haemolytica in calves concurrently inoculated with inactivated or modified-live preparations of M. haemolytica and viral combination vaccines containing modified-live bovine herpesvirus type 1.
        Am J Vet Res. 2011; 72: 1541-1549
        • Stoltenow C.
        • Cortese V.S.
        • Seeger J.T.
        • et al.
        Immunologic responses of beef calves to concurrent application of modified-live viral vaccine (intranasal and systemic administration) and systemically administered mannheimia haemolytica bacterin-leukotoxoid.
        Bov Pract. 2011; 45: 132-139
        • Ellis J.
        • Gow S.
        • Berenik A.
        • et al.
        Comparative efficacy of modified-live and inactivated vaccines in boosting responses to bovine respiratory syncytial virus following neonatal mucosal priming of beef calves.
        Can Vet J. 2018; 59: 1311-1319
        • Cortese V.S.
        • Seeger J.T.
        • Trejo C.
        • et al.
        The impact of neonatal intranasal vaccination for bovine respiratory syncytial virus on subsequent vaccination and responses to natural exposure.
        JSM Allergy Asthma. 2018; 3: 1021